Novartis AG

About Novartis AG

Novartis AG is a global healthcare company based in the UK, dedicated to discovering and developing innovative medicines to improve and extend people’s lives. With a strong commitment to research and development, Novartis focuses on areas such as oncology, cardiology, immunology, and neuroscience.

The company operates through two main divisions: Innovative Medicines and Sandoz. The Innovative Medicines division includes patented pharmaceuticals, while Sandoz specializes in generic and biosimilar medicines, ensuring access to high-quality healthcare for patients worldwide.

Novartis is driven by a vision to reimagine medicine, aiming to address the evolving needs of patients and healthcare systems. The company invests significantly in cutting-edge technologies and collaborations with leading research institutions to accelerate drug discovery and development.

With a diverse portfolio of products, Novartis is committed to providing solutions that meet the unique needs of patients. The company also prioritizes sustainability and ethical practices, striving to make a positive impact on society and the environment.

In addition to its focus on innovation, Novartis actively engages in partnerships with healthcare professionals, patient organizations, and governments to enhance healthcare delivery and outcomes. The company’s dedication to patient-centric approaches ensures that their therapies are designed with the patient’s best interests in mind.

As a leader in the pharmaceutical industry, Novartis continues to push the boundaries of science and technology, working tirelessly to bring new treatments to market and improve the quality of life for patients around the globe.